HC Wainwright Predicts Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP) – HC Wainwright issued their FY2029 earnings estimates for shares of Edap Tms in a research report issued to clients and investors on Friday, March 28th. HC Wainwright analyst S. Ramakanth expects that the medical equipment provider will earn $0.40 per share for the year. HC Wainwright has a “Buy” rating and a $19.00 price objective on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share.

Several other research firms have also issued reports on EDAP. StockNews.com assumed coverage on Edap Tms in a research report on Friday. They set a “hold” rating on the stock. Piper Sandler dropped their target price on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a report on Friday.

Edap Tms Trading Down 3.2 %

NASDAQ:EDAP opened at $2.15 on Monday. The company has a market cap of $79.77 million, a PE ratio of -3.31 and a beta of 0.37. The business’s 50 day moving average is $2.42 and its two-hundred day moving average is $2.50. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. Edap Tms has a 52 week low of $1.96 and a 52 week high of $8.50.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.06. The business had revenue of $22.69 million for the quarter, compared to analysts’ expectations of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%.

Hedge Funds Weigh In On Edap Tms

Several institutional investors have recently made changes to their positions in EDAP. BNP Paribas Financial Markets boosted its position in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the period. Parkman Healthcare Partners LLC bought a new stake in Edap Tms in the third quarter valued at $395,000. Orion Capital Management LLC boosted its holdings in shares of Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares during the period. Illumine Investment Management LLC bought a new position in shares of Edap Tms during the fourth quarter worth about $50,000. Finally, Rock Springs Capital Management LP increased its holdings in shares of Edap Tms by 1.5% in the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after acquiring an additional 23,800 shares during the period. 62.74% of the stock is owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.